SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001297184-24-000019
Filing Date
2024-04-12
Accepted
2024-04-12 16:08:07
Documents
18
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A amph-20240603xdef14a.htm   iXBRL DEF 14A 2134768
2 GRAPHIC amph-20240603xdef14a017.jpg GRAPHIC 104298
3 GRAPHIC amph-20240603xdef14a018.jpg GRAPHIC 88638
4 GRAPHIC amph-20240603xdef14a019.jpg GRAPHIC 95314
5 GRAPHIC amph-20240603xdef14a021.jpg GRAPHIC 7807
  Complete submission text file 0001297184-24-000019.txt   3999618

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20240603.xsd EX-101.SCH 7316
7 EX-101.DEF amph-20240603_def.xml EX-101.DEF 10918
8 EX-101.LAB amph-20240603_lab.xml EX-101.LAB 17376
9 EX-101.PRE amph-20240603_pre.xml EX-101.PRE 8218
21 EXTRACTED XBRL INSTANCE DOCUMENT amph-20240603xdef14a_htm.xml XML 374740
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36509 | Film No.: 24841507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)